Social Media Talk about Diabetes Medicines and the Popularity of GLP-1 Treatments

The FDA's expansion of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has led to increased public visibility of antidiabetic drugs (ADDs).

• GLP-1 RAs are now commonly prescribed for weight loss.
• The rise in popularity of these drugs is evident in online public discussions.
• The clinical use of ADDs has evolved alongside changing perceptions and applications.

Simplified